Healthcare information technology company Xifin, San Diego, has expanded its laboratory information system, Xifin LIS Anywhere, with the launch of a next-generation sequencing (NGS) module to provide advanced workflow functionality for laboratory sequencing operations and precision medicine. Xifin LIS Anywhere for NGS was showcased at the annual meeting of the College of American Pathologists, held in October.
Xifin LIS Anywhere is an advanced laboratory information system that includes robust solutions for anatomic pathology, genomics, molecular diagnostics, and toxicology. The diagnostic platform supports Xifin ProNet, a collaborative clinical data management solution that facilitates Cloud-based digital pathology as well as physician collaboration through the exchange of key data, images, and reports.
The NGS module expands Xifin’s suite of genomics-based LIS workflow tools to help labs grow molecular lines of business, drive adoption of sequencing tests, and improve the genomics workflow for better patient outcomes and maximum return on investment.
NGS has transformed the genomics and molecular diagnostics landscape. According to Allied Market Research, the global market for NGS is expected to reach $12.8 billion by 2022.1 Technological advances in NGS platforms, increasing applications, and unprecedented adoption of NGS among research laboratories and academic institutions are driving the growth of the market.
Lâle White, Xifin.
“Xifin continues to invest in genomics-based LIS and genetic analysis solutions—including pharmacogenomics testing and interpretation, polymerase chain reaction methods, telegenetic counseling services, and our newly launched next-generation sequencing module—to help innovative labs grow new business lines and support precision medicine initiatives,” says Lâle White, CEO of Xifin. “In addition, Xifin ProNet enables precise tracking of patient response to therapy lines by combining clinical narratives with patient-level data, imaging, and NGS results.”
Xifin LIS Anywhere for NGS provides intuitive Cloud-based workflow management to support the sequencing operations of genomic laboratories for commercial testing. The end-to-end workflow solution enables laboratories to drive growth of business lines by improving sequencing operations through efficient wet lab management, extending the anatomic pathology module for technical component/professional component splits, and facilitating Cloud-based digital images as well as physician collaboration. Xifin LIS Anywhere for NGS improves sequencing efficiencies through the following capabilities:
- Clinical trials management.
- Configurable batch processing.
- Interoperability and connectivity.
- Laboratory procedure/protocol management.
- Plate management.
- Reporting.
The NGS module is delivered as part of Xifin LIS Anywhere, or can also be used to augment less-robust LIS or research-oriented laboratory information management systems.
For more information, visit Xifin Inc.
REFERENCE
-
Sumant O, Shaikh S. Next-Generation Sequencing (NGS) Market by Product (Consumables, Platforms, and Services), by Application (Diagnostics, Biomarkers and Cancer, Reproductive Health), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single-Molecule Real-Time Sequencing, Other Technologies): Global Opportunity Analysis and Industry Forecast, 2014–2011. Portland, Ore: Allied Market Research, 2017. Available at: www.alliedmarketresearch.com/next-generation-sequencing-market. Accessed November 10, 2017.
